BTZ was previously shown to induce apoptosis in the “stem cell like” blasts from AML patients [9], so it was used in the present study to target the ALDH-positive “stem-like” cells in the Ara-C resistant CMY cell line, in comparison to the ALDH inhibitor DSF/Cu2+. Here, CASC3 is linked to acute myeloid leukemia.